Shukra Pharmaceuticals Limited (BOM:524632)
India flag India · Delayed Price · Currency is INR
41.51
+0.08 (0.19%)
At close: Aug 17, 2026

Shukra Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-59.76121.1899.839.732.9
Cash & Short-Term Investments
59.7659.76121.1899.839.732.9
Cash Growth
-50.68%-50.68%21.41%151.21%1271.89%-42.59%
Accounts Receivable
-229.4887.67245.13301.8774.01
Other Receivables
--193.2564.6782.3-
Receivables
-251.79383.22329.59406.9599.5
Inventory
-139.0399.5323.1431.5739.54
Prepaid Expenses
--0.110.170.220.59
Other Current Assets
-387.5250.24109.6252.2516.2
Total Current Assets
-838.1654.27562.33530.72158.72
Property, Plant & Equipment
-336.3213.43216.05218.95192.41
Total Assets
-1,174867.7778.37749.66351.13

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-100.6592.1672.21336.2285.9
Accrued Expenses
--15.3710.819.1810.33
Current Portion of Long-Term Debt
-18.2710.644.9713.132.5
Current Unearned Revenue
--26.4435.2866.1224.68
Other Current Liabilities
-112.0128.2218.250.420.36
Total Current Liabilities
-230.92172.84141.53425.06123.77
Long-Term Debt
-31.9331.1326.5737.6831.27
Pension & Post-Retirement Benefits
-1.141.271.151.08-
Long-Term Deferred Tax Liabilities
-11.9134.1132.7332.8732.6
Other Long-Term Liabilities
-0---0-0
Total Liabilities
-275.91239.34201.98496.7187.63

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-437.88437.88109.4739.1415.66
Additional Paid-In Capital
--47.491.1922.79-
Retained Earnings
--143375.66191.13147.84
Comprehensive Income & Other
-460.610.080.08-0.09-
Shareholders' Equity
898.49898.49628.36576.4252.97163.5
Total Liabilities & Equity
-1,174867.7778.37749.66351.13

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
50.250.241.7731.5450.8233.77
Net Cash (Debt)
9.579.5779.4168.27-11.09-30.87
Net Cash Growth
-87.95%-87.95%16.33%---
Net Cash Per Share
0.020.020.180.16-0.16-0.49
Filing Date Shares Outstanding
431.95429.05437.88438.39438.3962.63
Total Common Shares Outstanding
431.95429.05437.88438.39438.3962.63
Working Capital
-607.18481.44420.79105.6634.95
Book Value Per Share
2.092.091.441.310.582.61
Tangible Book Value
898.49898.49628.36576.4252.97163.5
Tangible Book Value Per Share
2.092.091.441.310.582.61
Land
--1.721.721.721.7
Buildings
--125.26125.26116.73100.5
Machinery
--307.27282.68277.22248.6
Construction In Progress
--19.4516.6216.6216.62